Osteomyelitis — infection of bone and bone marrow — remains one of the most challenging infectious diseases in clinical practice, requiring prolonged antibiotic therapy often measured in weeks, surgical debridement of necrotic tissue, and meticulous wound care that can span months. In the United States, the overall incidence is approximately 21.8 cases per 100,000 person-years, with rates sharply increasing in diabetic patients, the elderly, and individuals with peripheral vascular disease. For nursing students, osteomyelitis is a high-yield NCLEX topic that bridges musculoskeletal nursing, infection control, wound management, IV therapy, and patient education. This reference covers pathophysiology, both major classification systems, organism identification by patient population, acute versus chronic presentation, the full diagnostic workup, medical and surgical management, systematic nursing assessment, nursing diagnoses with evidence-based interventions, OPAT nursing, wound care specifics, special populations, and six NCLEX-style practice questions with detailed rationales.
Use this page alongside the fractures nursing reference for open fracture and compartment syndrome content, the wound assessment guide for systematic wound evaluation, the sepsis nursing reference for hematogenous spread and sepsis recognition, the diabetes mellitus nursing reference for diabetic foot management, the AKI nursing reference for nephrotoxicity monitoring during prolonged antibiotic therapy, and the nursing lab values cheat sheet for ESR, CRP, and WBC interpretation.
Fast-scan summary
| Parameter | Key facts |
|---|---|
| Definition | Infection of bone and bone marrow caused by bacteria (most common), fungi, or mycobacteria; may be acute (<2 weeks) or chronic (>6 weeks) |
| Types by route | Hematogenous (blood-borne), contiguous focus (adjacent soft tissue infection or surgery), direct inoculation (open fracture, penetrating wound) |
| Most common organism | Staphylococcus aureus accounts for 60–80% of all osteomyelitis cases across age groups |
| Most common sites | Adults: vertebral bodies, feet (diabetic); Children: long bone metaphyses (tibia, femur, humerus) |
| Key assessment findings | Localized bone pain disproportionate to exam, warmth, erythema, swelling; fever (acute); draining sinus tracts (chronic) |
| Gold standard imaging | MRI — sensitivity 90–100%, specificity 80–90%; plain radiographs lag 10–14 days behind pathology |
| Gold standard for organism ID | Bone biopsy with culture and histopathology (surface wound swabs are unreliable) |
| Treatment duration | IV antibiotics 4–6 weeks (acute); chronic may require 3+ months plus surgical debridement |
| Nursing priorities | IV antibiotic administration and monitoring, PICC line care, wound assessment and care, pain management, immobilization of affected limb, patient education on long-term adherence |
| NCLEX high-yield point | Blood cultures BEFORE starting antibiotics; Salmonella spp. in sickle cell disease; vancomycin for empiric MRSA coverage |
Pathophysiology
Bone infection develops through one of three mechanisms. In hematogenous osteomyelitis, bacteria enter the bloodstream from a remote focus — a urinary tract infection, endocarditis, an infected IV catheter — and seed in bone. This route predominates in children (long bone metaphyses) and older adults (vertebral bodies). In contiguous-focus osteomyelitis, infection spreads from adjacent soft tissue — after open fracture, prosthetic joint surgery, or through a diabetic foot ulcer that erodes to bone. In direct inoculation, organisms are introduced through penetrating trauma, an open fracture, or a surgical procedure.
Why bone infections are difficult to eradicate
The vascular anatomy of bone is central to understanding why osteomyelitis is so resistant to treatment. Bone cortex receives blood through periosteal and endosteal vessels. When bacteria colonize the medullary canal, the resulting inflammation increases intraosseous pressure, compressing the thin-walled venous sinusoids and nutrient vessels. The resulting ischemia causes bone necrosis, producing a sequestrum — a fragment of dead, avascular bone that is walled off from the blood supply and therefore inaccessible to systemic antibiotics and immune cells. Over time, the periosteum lifts off the bone surface and forms new reactive bone called the involucrum, which encases the infection. Pus may track through openings in the involucrum called cloacae, eventually forming draining sinus tracts to the skin surface.
Biofilm formation
Staphylococcus aureus and other organisms produce biofilm — a polysaccharide matrix that adheres to bone, dead tissue, and orthopedic hardware. Bacteria within biofilm exist in a metabolically quiescent state (sessile phenotype) that is 100–1,000 times more resistant to antibiotics than planktonic (free-floating) bacteria. Biofilm also shields organisms from neutrophils and macrophages. This is the primary reason chronic osteomyelitis relapses after antibiotic courses and why surgical debridement of all necrotic tissue is essential: antibiotics alone cannot sterilize biofilm-encased bone.
Classification systems
Two classification systems are widely used. The Waldvogel classification categorizes osteomyelitis by mechanism and duration. The Cierny-Mader classification provides a surgical staging system that guides treatment decisions.
Waldvogel classification
| Category | Mechanism | Typical patients | Common sites |
|---|---|---|---|
| Hematogenous | Blood-borne bacterial seeding from a distant focus | Children (long bones), older adults (vertebral), IV drug users | Metaphyses of long bones (children), vertebral bodies (adults) |
| Contiguous focus — adequate vascularity | Spread from adjacent soft tissue or post-surgical; patient has intact blood supply | Post-operative patients, open fractures, soft tissue infections adjacent to bone | Tibia (post-fracture fixation), sternum (post-CABG), skull (post-craniotomy) |
| Contiguous focus — vascular insufficiency | Spread from adjacent tissue in a patient with poor arterial perfusion | Diabetics, peripheral arterial disease, neuropathy | Metatarsals, phalanges, calcaneus (foot) |
Cierny-Mader staging system
| Component | Stage/Class | Description |
|---|---|---|
| Anatomic type | Stage I — Medullary | Infection confined to the intramedullary canal (endosteal surface); hematogenous spread typical |
| Stage II — Superficial | Infection limited to the cortical bone surface; contiguous-focus origin; often from an overlying soft tissue defect | |
| Stage III — Localized | Full-thickness cortical involvement (medullary + cortical), but bone remains mechanically stable after debridement | |
| Stage IV — Diffuse | Through-and-through bone destruction; bone mechanically unstable; debridement would require stabilization or reconstruction | |
| Physiologic host class | Host A — Normal | Healthy patient with intact immune function and normal wound healing capacity |
| Host B — Compromised | Local (BL) or systemic (BS) compromise: diabetes, PAD, chronic steroid use, malnutrition, tobacco use, immunosuppression | |
| Host C — Prohibitive | Treatment morbidity would exceed the disease itself; may include terminally ill patients or those with minimal functional impairment from the infection |
Clinical application: A Stage IV-B patient (diffuse bone involvement in a compromised host) has poor surgical candidacy and may require suppressive oral antibiotics or amputation. A Stage I-A patient (medullary infection in a healthy host) often responds to IV antibiotics alone without surgery.
Etiology and organisms by patient population
| Patient population | Most common organisms | Clinical notes |
|---|---|---|
| Adults (general) | Staphylococcus aureus (60–80%), Streptococcus spp., gram-negative bacilli (E. coli, Proteus) | S. aureus is the most common cause of osteomyelitis in all age groups |
| Neonates (<4 months) | Group B Streptococcus, S. aureus, E. coli, gram-negative enterics | Hematogenous spread; may present with pseudoparalysis (refusal to move limb) rather than obvious fever |
| Children (4 months–adult) | S. aureus, Group A Streptococcus, Kingella kingae (age <5) | Metaphyseal predilection due to sluggish blood flow in metaphyseal capillary loops |
| Sickle cell disease | Salmonella spp. (most common), S. aureus | High-yield NCLEX fact: Salmonella is the most common osteomyelitis organism in sickle cell patients; functional asplenia impairs clearance of encapsulated organisms |
| Diabetics / vascular insufficiency | Polymicrobial: S. aureus, Streptococcus, gram-negatives (Pseudomonas, Enterobacteriaceae), anaerobes (Bacteroides, Peptostreptococcus) | Often requires broad-spectrum coverage; wound cultures may underrepresent deep bone flora |
| Post-surgical / hardware-associated | S. aureus, Staphylococcus epidermidis (coagulase-negative staph), MRSA | S. epidermidis forms dense biofilm on orthopedic hardware; may require hardware removal for cure |
| IV drug users | Pseudomonas aeruginosa, S. aureus, gram-negative bacilli, Candida spp. | Often multifocal; vertebral involvement common; evaluate for concurrent endocarditis |
| MRSA prevalence | Methicillin-resistant S. aureus | Community-acquired MRSA (CA-MRSA) now accounts for 30–50% of S. aureus osteomyelitis in many regions; empiric vancomycin required until cultures confirm susceptibility. See the MRSA nursing reference for contact precautions, vancomycin monitoring, and decolonization protocol. |
Clinical presentation: acute versus chronic
| Feature | Acute osteomyelitis (<2 weeks onset) | Chronic osteomyelitis (>6 weeks or relapsing) |
|---|---|---|
| Fever | High-grade (38.5°C/101.3°F or above), often with chills and rigors | Low-grade or absent; afebrile periods between flares |
| Pain | Severe, constant, localized bone pain; worsened by weight-bearing or palpation | Dull, aching pain; may wax and wane over months |
| Swelling and erythema | Significant soft tissue swelling, warmth, erythema over affected bone | Mild to moderate; may be confined to area around sinus tract |
| Range of motion | Markedly decreased due to pain and swelling | May be limited due to joint contracture or guarding |
| Drainage | Uncommon early; may develop if abscess forms | Draining sinus tracts (hallmark) — purulent, serosanguineous, or foul-smelling |
| Systemic signs | Malaise, fatigue, tachycardia; may progress to sepsis | Fatigue, weight loss; frank sepsis uncommon except during acute flares |
| Lab markers | Elevated WBC, ESR (typically >70 mm/hr), CRP (often >50 mg/L) | WBC may be normal; ESR and CRP mildly elevated or normal between flares |
Site-specific presentations
- Vertebral osteomyelitis (spondylodiscitis): Insidious back pain that worsens over weeks, often misdiagnosed as mechanical back pain. Fever present in only 50% of cases. New neurologic deficits (radiculopathy, weakness, bowel/bladder dysfunction) require emergent MRI to rule out epidural abscess.
- Long bone osteomyelitis: Classic presentation with localized tenderness, warmth, and swelling over the affected metaphysis or diaphysis. In children, limp or refusal to bear weight may be the primary finding.
- Diabetic foot osteomyelitis: Often clinically silent until advanced — neuropathy masks pain. A non-healing ulcer that exposes bone or a positive probe-to-bone test (metal probe passes to bone through the ulcer) has a positive predictive value of 89% for osteomyelitis.
Diagnostics
| Test | Details | Clinical significance |
|---|---|---|
| WBC count | May be elevated (>12,000/mm3) in acute; often normal in chronic | Nonspecific; normal WBC does not rule out osteomyelitis |
| ESR (erythrocyte sedimentation rate) | Elevated in >90% of cases; typically >70 mm/hr in acute osteomyelitis | Slow to normalize (weeks); useful for monitoring long-term treatment response but slow to reflect acute changes |
| CRP (C-reactive protein) | Elevated in >95% of cases; rises within 6 hours of infection onset | Best marker for treatment response — half-life ~19 hours; should decline by 50% within first week of effective therapy. Failure to decline suggests treatment failure or undrained collection |
| Blood cultures | Positive in 30–50% of hematogenous cases; lower yield in contiguous | Obtain two sets (aerobic + anaerobic) BEFORE starting antibiotics — high-yield NCLEX point; positive cultures may eliminate need for bone biopsy |
| Plain radiograph (X-ray) | Periosteal elevation, cortical erosion, lytic lesions | Changes lag 10–14 days behind pathology; initial X-ray may be normal. Useful for baseline and follow-up |
| MRI | Sensitivity 90–100%, specificity 80–90%; shows marrow edema, abscess, soft tissue extent | Gold standard imaging modality. T1-weighted: low signal in affected marrow. T2/STIR: high signal indicating edema. Gadolinium enhancement shows abscess rim |
| CT scan | Superior for cortical bone detail, sequestrum identification, surgical planning | Useful when MRI is contraindicated (pacemaker, metallic implants) or for surgical planning of debridement |
| Three-phase bone scan (Tc-99m) | High sensitivity (~95%) but low specificity (~30%); all three phases positive in osteomyelitis | Useful when MRI is unavailable; cannot distinguish osteomyelitis from other causes of increased bone turnover (fracture healing, Charcot foot) |
| Bone biopsy with culture | Percutaneous or open surgical; specimens sent for aerobic, anaerobic, fungal culture and histopathology | Gold standard for identifying the causative organism. Essential for directing antibiotic therapy. Should be performed before or after a 48-hour antibiotic holiday when possible |
| Wound/surface swab culture | Frequently grows skin flora colonizers or superficial organisms | Unreliable for identifying the bone pathogen — surface swab cultures correlate with bone biopsy cultures in only 30–40% of cases. Deep tissue biopsy is required for accurate identification |
Medical management: antibiotic therapy
Principles
Antibiotic therapy for osteomyelitis is prolonged and guided by culture and sensitivity data whenever possible. The Infectious Diseases Society of America (IDSA) guidelines recommend culture-directed therapy as the standard. Empiric therapy is initiated after blood cultures (and ideally bone biopsy) are obtained, then narrowed once sensitivities return.
Antibiotic regimens
| Phase | Duration | Details |
|---|---|---|
| Empiric therapy (before cultures) | Until culture results (48–72 hours) | Vancomycin (MRSA coverage) + ceftriaxone or piperacillin-tazobactam (gram-negative coverage). Adjust based on local antibiogram and patient risk factors |
| Culture-directed IV therapy | 4–6 weeks total for acute; 6–8+ weeks for chronic | MSSA: nafcillin or cefazolin. MRSA: vancomycin (monitor trough or AUC/MIC). Gram-negative: ceftriaxone, cefepime, or fluoroquinolone based on sensitivity. Polymicrobial (diabetic): broad-spectrum per culture data |
| Oral step-down (selected cases) | Varies; may complete remaining course orally after initial IV phase | The OVIVA trial (2019) demonstrated non-inferiority of oral step-down after initial IV phase for bone and joint infections. Options: fluoroquinolones (excellent bone penetration) for gram-negatives; linezolid or trimethoprim-sulfamethoxazole for MRSA; rifampin as adjunctive agent for biofilm-associated infections (never as monotherapy — rapid resistance develops) |
Vancomycin monitoring
Vancomycin is the empiric drug of choice for suspected MRSA osteomyelitis. Current IDSA/ASHP guidelines (2020) recommend AUC/MIC-guided dosing (target AUC24/MIC 400–600) rather than trough-only monitoring. Nursing responsibilities include:
- Drawing trough levels 30 minutes before the fourth dose (steady state)
- Monitoring serum creatinine and BUN at least twice weekly — vancomycin nephrotoxicity incidence increases significantly after 7 days of therapy and with concurrent nephrotoxins (see AKI nursing reference)
- Assessing for ototoxicity: tinnitus, hearing changes, vertigo
- Monitoring for red man syndrome during infusion (histamine-mediated; rate-related — slow infusion to >60 minutes)
- Reporting supratherapeutic levels (>20 mcg/mL trough) promptly
OPAT: outpatient parenteral antibiotic therapy
Most patients with osteomyelitis complete their IV antibiotic course at home through OPAT programs, reducing hospitalization from weeks to days. The nurse’s role in OPAT is covered in detail below.
Surgical management
| Procedure | Indication | Nursing considerations |
|---|---|---|
| Debridement and irrigation | Acute or chronic with necrotic tissue, abscess, or failure to respond to antibiotics within 48–72 hours | Post-op wound assessment for drainage volume, color, and odor; maintain drain patency; monitor hemoglobin (debridement can cause significant blood loss) |
| Sequestrectomy | Chronic osteomyelitis with identified sequestrum on imaging | Removal of avascular dead bone that harbors bacteria and biofilm; antibiotics cannot reach sequestrum because it has no blood supply |
| Bone grafting | Stage III–IV disease after debridement leaves bone defects | Cancellous autograft (iliac crest), cortical allograft, or antibiotic-impregnated cement spacer. Monitor graft site for infection, hematoma |
| Negative pressure wound therapy (NPWT/VAC) | Large soft tissue defects after debridement; promotes granulation | Maintain continuous or intermittent negative pressure (typically −125 mmHg); assess wound bed at each dressing change (every 48–72 hours); document granulation tissue percentage; monitor for bleeding at wound edges |
| Hyperbaric oxygen therapy (HBOT) | Adjunctive for refractory chronic osteomyelitis, especially diabetic foot | Enhances leukocyte killing, promotes angiogenesis, increases antibiotic efficacy in hypoxic tissue. Nursing: assess ears for barotrauma, monitor blood glucose (HBOT can cause hypoglycemia in diabetic patients) |
| Hardware removal | Infected orthopedic implants when infection cannot be controlled with retention | Decision between retention (with debridement + prolonged antibiotics) versus removal depends on implant stability, duration of infection, and organism. S. epidermidis biofilm on hardware often requires removal for cure |
| Amputation | Refractory chronic osteomyelitis with vascular insufficiency (Cierny-Mader Stage IV-B/C); life-threatening sepsis; intractable pain | Last resort. Most common in diabetic foot osteomyelitis with non-reconstructable vascular disease. Pre-op: vascular surgery evaluation, psychosocial support, rehabilitation planning |
Nursing assessment
Systematic assessment approach
Vital signs: Assess temperature every 4 hours (every 1–2 hours if febrile). Document fever patterns — spiking fevers suggest undrained abscess or bacteremia. Tachycardia and hypotension may indicate progression to sepsis.
Wound assessment: For patients with open wounds, sinus tracts, or post-surgical sites, perform systematic wound evaluation at each dressing change using the framework from the wound assessment guide:
- Location, size (length x width x depth in centimeters)
- Wound bed: percentage of granulation (red), slough (yellow), eschar (black), exposed bone (white/gray)
- Exudate: amount (scant, moderate, copious), color (serous, serosanguineous, purulent), odor
- Wound edges and periwound skin: maceration, erythema, induration, warmth extending beyond wound margin
- Tunneling and undermining: document direction (clock method) and depth
- Probe-to-bone: if applicable (diabetic foot — document positive or negative)
Neurovascular assessment of affected extremity: Perform the 6 Ps assessment as described in the fractures nursing reference:
| Assessment (6 Ps) | What to evaluate | Concern if abnormal |
|---|---|---|
| Pain | Location, quality, intensity (0–10), worsened by passive stretch? | Pain disproportionate to exam or worsening despite analgesia may indicate compartment syndrome or abscess expansion |
| Pallor | Skin color compared to contralateral limb | Pallor, mottling, or cyanosis suggests vascular compromise |
| Pulselessness | Palpate distal pulses (dorsalis pedis, posterior tibial, radial, ulnar) | Diminished or absent pulses indicate arterial compromise |
| Paresthesia | Numbness, tingling, altered sensation in distal extremity | Early sign of nerve compression or ischemia |
| Paralysis | Ability to move digits and joints distal to affected area | Late and ominous sign — indicates significant neurovascular compromise |
| Poikilothermia | Temperature of extremity compared to contralateral side | Cool extremity relative to other side suggests impaired perfusion |
Pain assessment (PQRST): Osteomyelitis pain is typically deep, constant, and aching. Use the PQRST framework: Provocation (weight-bearing, palpation), Quality (deep, boring, throbbing), Region/Radiation, Severity (0–10 scale), Timing (constant vs intermittent, nighttime worsening).
Psychosocial assessment: Prolonged treatment courses (6+ weeks of IV antibiotics, multiple surgeries, months of wound care) create significant psychological burden. Assess for depression, anxiety, non-adherence risk, social support, financial concerns related to prolonged treatment, substance use history (important for adherence and PICC line management), and body image concerns (especially with amputation or disfiguring wounds).
Nursing diagnoses and interventions
| Nursing diagnosis | Related factors | Interventions | Expected outcomes |
|---|---|---|---|
| Acute/chronic pain | Bone infection, inflammatory process, surgical debridement, prolonged immobilization | 1. Administer analgesics on schedule (not PRN alone) for consistent pain control — opioids for acute post-surgical, NSAIDs for chronic inflammation (verify renal function first) 2. Elevate affected extremity above heart level to reduce edema and pressure 3. Immobilize limb with splint or brace as ordered to prevent pathologic fracture and reduce pain with movement 4. Apply ice packs (20 min on/20 min off) to reduce swelling in acute phase; use barrier between ice and skin |
Patient reports pain at ≤4/10 on numeric scale; demonstrates ability to perform ADLs within prescribed activity restrictions |
| Impaired tissue integrity | Infectious process destroying bone and soft tissue, surgical debridement creating wound defects, draining sinus tracts | 1. Perform wound care using strict aseptic technique per provider orders — irrigate with normal saline, pack wound loosely to allow drainage, apply appropriate dressing 2. Maintain NPWT device if ordered — ensure seal integrity, document output, report sudden increase in drainage or frank bleeding 3. Optimize nutrition: high-protein diet (1.25–1.5 g/kg/day), vitamin C 500 mg BID, zinc supplementation — consult dietitian for patients with poor intake or albumin <3.0 g/dL 4. Reposition every 2 hours; use pressure-redistribution surfaces; protect bony prominences adjacent to infection site |
Wound shows progressive healing with increasing granulation tissue; no new areas of necrosis; wound dimensions decrease over serial measurements |
| Risk for sepsis | Hematogenous spread of bone infection, bacteremia, surgical site contamination, immunocompromised state | 1. Monitor temperature every 4 hours; report new fever >38.3°C (101°F) or hypothermia <36°C (96.8°F) — both are SIRS criteria 2. Obtain blood cultures (two sets from two sites) before initiating or changing antibiotics 3. Administer IV antibiotics within 1 hour of order — time is critical in sepsis prevention (see sepsis reference) 4. Monitor CRP trend — failure to decline by 50% in the first week of therapy warrants escalation to the infectious disease team |
Patient remains afebrile; CRP trends downward; no signs of systemic inflammatory response or hemodynamic instability |
| Impaired physical mobility | Pain, prescribed weight-bearing restrictions, immobilization devices, post-surgical limitations | 1. Enforce prescribed weight-bearing status (NWB, TTWB, WBAT) — clarify order with surgeon and communicate to all nursing staff and patient 2. Consult physical therapy for safe transfer training, assistive device fitting (crutches, walker), and progressive mobility plan 3. Implement VTE prophylaxis: SCDs while in bed, low-molecular-weight heparin as ordered, encourage ankle pumps hourly while awake 4. Perform ROM exercises on unaffected joints to prevent deconditioning; isometric exercises for affected limb as permitted |
Patient demonstrates safe use of assistive devices; adheres to weight-bearing restrictions; no VTE events during hospitalization |
| Risk for complications (pathologic fracture, chronic conversion) | Structural bone weakening from infection and debridement, inadequate antibiotic duration, biofilm persistence | 1. Handle affected extremity gently — support above and below during repositioning; avoid twisting or torque forces on weakened bone 2. Enforce activity restrictions: no heavy lifting, no impact activities on affected limb until imaging confirms bone healing 3. Monitor for sudden increase in pain, deformity, or crepitus — report immediately as potential pathologic fracture 4. Educate patient on completing full antibiotic course — premature discontinuation is the leading cause of chronic conversion and relapse |
No pathologic fracture occurs; patient completes prescribed antibiotic course; follow-up imaging shows resolution of infection |
| Deficient knowledge | Long-term antibiotic therapy, wound care at home, PICC line self-management, activity restrictions, follow-up schedule | 1. Teach PICC line care: daily site inspection, dressing change every 7 days (transparent) or every 48 hours (gauze), flushing protocol (10 mL NS before and after each infusion, heparin lock per facility policy) 2. Demonstrate IV antibiotic preparation and administration for home OPAT; have patient return-demonstrate before discharge 3. Provide written wound care instructions with photographs showing normal vs concerning appearances 4. Review warning signs requiring immediate medical attention: fever >38.3°C, increased redness or swelling, purulent drainage, PICC line redness or swelling at insertion site, new numbness or weakness |
Patient verbalizes understanding of medication regimen; demonstrates PICC care correctly; identifies warning signs requiring medical attention |
Wound care nursing in osteomyelitis
Dressing selection by wound type
| Wound characteristic | Dressing type | Rationale |
|---|---|---|
| Deep cavity with moderate-heavy exudate | Calcium alginate rope or hydrofiber (Aquacel) loosely packed, covered with absorbent secondary dressing | Alginates absorb 15–20 times their weight in exudate; form gel that maintains moist wound bed; easily removed without traumatizing granulation tissue |
| Shallow wound with granulation, light exudate | Foam dressing (Mepilex) or hydrocolloid | Provides moist healing environment; foam absorbs moderate exudate; protects fragile granulation tissue from mechanical trauma |
| Wound with necrotic tissue / slough | Enzymatic debriding agent (collagenase/Santyl) under moisture-retentive dressing, or autolytic debridement with hydrogel | Selective debridement of necrotic tissue while preserving viable tissue; must be combined with surgical debridement for large areas of necrosis |
| Large soft tissue defect post-debridement | Negative pressure wound therapy (NPWT/VAC) | Applies controlled suction (−75 to −125 mmHg) to remove exudate, reduce edema, increase perfusion, and promote granulation. Contraindicated over exposed vessels, in active bleeding, or over malignant wounds |
| Draining sinus tract | Absorptive wick or alginate rope packed into tract; absorbent cover dressing | Keeps tract open to allow drainage (premature closure traps infection); pack loosely — tight packing impairs drainage and causes ischemia |
NPWT (wound VAC) nursing considerations
- Verify continuous seal — audible or visible alarm indicates air leak. Re-seal with additional adhesive drape strips before repositioning patient
- Document canister output volume and character every shift; report output >100 mL/hr or change to frank sanguineous drainage
- Dressing changes typically every 48–72 hours; pre-medicate with analgesic 30–60 minutes before removal (dressing removal from granulating wound is painful)
- After removing foam, irrigate wound with warm normal saline, assess wound bed and measure dimensions, apply new foam cut to wound shape (not extending beyond wound edges), seal with transparent adhesive drape, reconnect tubing, verify seal
- Patient education: do not disconnect or clamp tubing (infection risk increases after 2 hours off therapy); notify nurse for bathroom trips if tubing length is insufficient
OPAT nursing: outpatient parenteral antibiotic therapy
PICC line management
Most OPAT patients receive antibiotics through a peripherally inserted central catheter (PICC). The PICC is typically placed by interventional radiology or a vascular access nurse before discharge. Nursing responsibilities include:
- Site assessment: Inspect insertion site daily for erythema, swelling, tenderness, drainage, or catheter migration. Measure and document external catheter length at each assessment — a change of >2 cm suggests migration
- Dressing changes: Transparent semi-permeable dressing (e.g., Tegaderm CHG) changed every 7 days or sooner if soiled, damp, or loose. Gauze dressing changed every 48 hours. Use chlorhexidine for site antisepsis (allow to dry completely before applying new dressing)
- Flushing: 10 mL normal saline push-pause technique before and after each infusion; heparin lock per facility protocol for intermittent use
- Occlusion management: If resistance is met during flushing, do not force — assess for kinking, reposition patient, attempt gentle aspiration. Tissue plasminogen activator (tPA/alteplase) instillation may be ordered for catheter-related thrombus
Monitoring during OPAT
| Monitoring parameter | Frequency | Rationale |
|---|---|---|
| CBC with differential | Weekly | Monitor for neutropenia (beta-lactams, linezolid), thrombocytopenia (linezolid), eosinophilia (drug allergy/DRESS) |
| BMP (creatinine, BUN, potassium) | Twice weekly (vancomycin) or weekly (others) | Vancomycin nephrotoxicity — incidence increases after day 7 and with concurrent nephrotoxins (piperacillin-tazobactam, NSAIDs, aminoglycosides). See AKI reference |
| Vancomycin trough or AUC | Before 4th dose (steady state), then twice weekly | Target AUC24/MIC 400–600 per 2020 IDSA/ASHP guidelines; trough-only target (if used): 15–20 mcg/mL for serious infections |
| LFTs (AST, ALT, alkaline phosphatase) | Weekly | Hepatotoxicity monitoring — especially for nafcillin, ceftriaxone (biliary sludging), fluoroquinolones |
| CRP | Weekly | Treatment response: expect >50% decline by end of week 1; plateau or rise suggests treatment failure or new complication |
| ESR | Every 2–4 weeks | Slower to normalize than CRP; useful as long-term trend marker; persistent elevation at end of therapy raises concern for incomplete treatment |
| PICC site and function | Daily (patient self-assessment) + weekly nurse visit | PICC-related complications: infection (2–5%), thrombosis (3–8%), occlusion, migration, mechanical phlebitis |
Common OPAT complications
- PICC line infection (CLABSI): New fever, rigors, or erythema/purulence at insertion site. Action: obtain peripheral and catheter blood cultures simultaneously, hold infusion, notify provider — catheter removal may be required
- PICC-associated DVT: Upper extremity swelling, pain, or edema ipsilateral to PICC. Action: obtain duplex ultrasound; anticoagulation if confirmed (see DVT nursing reference if available)
- Antibiotic adverse effects: Rash (evaluate for DRESS syndrome if accompanied by eosinophilia and organ dysfunction), Clostridioides difficile colitis (new diarrhea — 3+ loose stools per day), nephrotoxicity (rising creatinine), cytopenias
- C. difficile colitis: Prolonged broad-spectrum antibiotics are a major risk factor. Educate patients on reporting new-onset watery diarrhea immediately. Stool testing (GDH + toxin or NAAT) should be ordered promptly
Patient education
| Topic | Key teaching points |
|---|---|
| Medication adherence | Complete the full antibiotic course even if symptoms improve early — premature discontinuation is the leading cause of relapse and chronic conversion. If transitioning to oral antibiotics, take at the scheduled times without skipping doses. Do not take antacids or dairy within 2 hours of fluoroquinolones (chelation reduces absorption) |
| PICC line self-care | Keep dressing clean and dry. Cover with plastic wrap and tape for bathing (no submersion). Inspect site daily for redness, swelling, or drainage. Flush line as taught before and after each infusion. Do not use affected arm for blood pressure measurement or venipuncture. Carry catheter emergency card |
| Wound care at home | Change dressings as instructed (demonstrate and return-demonstrate before discharge). Wash hands before and after wound care. Use clean technique at minimum; sterile supplies as provided. Keep wound log: date, drainage amount and color, wound dimensions if instructed to measure |
| Activity restrictions | Follow weight-bearing status prescribed by surgeon. Use assistive devices as instructed. No contact sports, heavy lifting, or high-impact activity until cleared by provider. Elevate limb when seated to reduce edema. Gentle ROM exercises as permitted |
| When to call the provider | Temperature >38.3°C (101°F) or chills/rigors. New or increased wound drainage, foul odor, or expanding redness. PICC site redness, swelling, or drainage. New numbness, weakness, or inability to move digits. Chest pain or shortness of breath (pulmonary embolism). Watery diarrhea ≥3 episodes/day (C. difficile). Rash, hives, or difficulty breathing (allergic reaction) |
| Follow-up schedule | Weekly OPAT clinic visits for labs, PICC assessment, and clinical evaluation. Repeat MRI or inflammatory markers at 4–6 weeks to assess treatment response. Orthopedic follow-up for bone healing assessment. Infectious disease follow-up to determine antibiotic duration and transition to oral therapy |
Complications
| Complication | Mechanism | Nursing implications |
|---|---|---|
| Chronic osteomyelitis | Incomplete eradication due to sequestrum, biofilm, or premature antibiotic discontinuation; relapsing course with periods of quiescence and flare | Educate on lifelong risk of relapse; chronic osteomyelitis can reactivate decades after initial treatment. Monitor for recurrent drainage, fever, or pain at the original site |
| Pathologic fracture | Structural weakening of bone from infection-mediated osteolysis and surgical debridement | Handle affected limb gently; enforce activity restrictions; report sudden pain, deformity, or crepitus. May require internal fixation after infection control |
| Septic arthritis | Contiguous spread from infected bone into adjacent joint space, especially when metaphysis is intra-articular (hip in children, shoulder) | Assess adjacent joints for effusion, warmth, and pain with movement. Joint aspiration is diagnostic. Requires emergent surgical drainage |
| Sinus tract formation | Chronic infection creates a channel from bone through soft tissue to skin surface; provides continuous drainage pathway | Keep sinus tract open (premature closure traps infection); document tract depth and drainage characteristics at each assessment |
| Marjolin ulcer (squamous cell carcinoma) | Malignant transformation of epithelium lining long-standing draining sinus tracts — typically after 20–30 years of chronic osteomyelitis | Biopsy any change in a chronic sinus tract: increased pain, change in drainage character, raised wound edges, excessive granulation tissue, bleeding. Rare but important long-term complication |
| Amputation | Required for refractory infection in a limb with non-reconstructable vascular disease or when infection threatens life (overwhelming sepsis) | Pre-operative psychosocial support, rehabilitation referral, phantom limb pain education, prosthetic evaluation. Most common in diabetic foot osteomyelitis |
| Antibiotic toxicity | Nephrotoxicity (vancomycin, aminoglycosides), hepatotoxicity (nafcillin, fluoroquinolones), myelosuppression (linezolid), C. difficile colitis (all broad-spectrum agents), tendinopathy (fluoroquinolones) | Monitor labs per OPAT schedule above; educate patients on reporting new symptoms (decreased urine output, jaundice, diarrhea, tendon pain). See AKI reference for nephrotoxicity detail |
Special populations
Diabetic foot osteomyelitis
Diabetic foot osteomyelitis is the most common form of contiguous-focus osteomyelitis with vascular insufficiency and the leading cause of non-traumatic lower-extremity amputation. It develops when a neuropathic foot ulcer penetrates to bone. Key clinical points:
- Probe-to-bone test: A sterile blunt metal probe is passed through the ulcer — if it contacts hard, gritty bone, the test is positive (sensitivity 66%, specificity 85%, PPV 89% in high-risk patients). This bedside test can be performed by trained nurses
- Diabetic neuropathy masks symptoms: Patients often lack pain despite deep infection. The absence of pain does not rule out osteomyelitis. Rely on wound depth, exposed bone, and inflammatory markers
- Vascular assessment is critical: Assess pedal pulses and ankle-brachial index (ABI). An ABI <0.4 or absent pedal pulses indicates severe PAD that compromises antibiotic delivery and wound healing — vascular surgery referral before or concurrent with osteomyelitis treatment
- Glycemic control affects outcomes: Hyperglycemia impairs neutrophil function and wound healing. Target glucose <180 mg/dL in hospitalized patients per ADA guidelines (see diabetes mellitus nursing reference)
- Amputation rates: Up to 40% of diabetic foot osteomyelitis cases result in some level of amputation. Early, aggressive treatment and multidisciplinary care (infectious disease, vascular surgery, podiatry, wound care, endocrinology) improve limb salvage rates
Vertebral osteomyelitis (spondylodiscitis)
Vertebral osteomyelitis accounts for 3–5% of all osteomyelitis cases and is the most common form of hematogenous osteomyelitis in adults over 50. The lumbar spine is most frequently affected, followed by thoracic and cervical.
- Presentation: Insidious onset back pain over weeks to months, worsening despite rest. Fever is present in only 50% of cases. The diagnosis is frequently delayed (average 2–4 months from symptom onset)
- Red flags requiring emergent MRI: New neurologic deficits (weakness, numbness, bowel/bladder dysfunction) — these suggest epidural abscess with spinal cord compression, a neurosurgical emergency
- Nursing assessment: Neurologic checks every 4 hours in the acute phase: lower extremity strength, sensation, deep tendon reflexes, rectal tone. Document and report any deterioration immediately
- Treatment: IV antibiotics for 6–8 weeks minimum; surgical decompression and stabilization for epidural abscess with neurologic compromise, spinal instability, or failure of medical therapy
- Activity: Bed rest during acute phase; external bracing (TLSO brace) for spinal stabilization; progressive mobilization guided by pain and imaging
Hematogenous osteomyelitis in children
- Metaphyseal predilection: In children, the metaphyseal capillary loops adjacent to the growth plate have sluggish, turbulent blood flow that allows bacterial seeding. The growth plate (physis) acts as a barrier to spread into the epiphysis — except in neonates, where transphyseal vessels allow spread into the joint
- Growth plate involvement: Infection that damages the physis can cause growth disturbance (limb length discrepancy, angular deformity). Long-term orthopedic follow-up is essential
- Clinical clues: Limp, refusal to bear weight, or pseudoparalysis in a child with fever warrants urgent evaluation. Children may not localize pain accurately — examine the entire limb
- Treatment: IV antibiotics for 3–5 days followed by oral step-down (shorter IV courses than adults) per current pediatric infectious disease guidelines; surgical drainage for subperiosteal abscess or failure to improve within 48–72 hours
IV drug use-associated osteomyelitis
- Multifocal involvement: Unlike other forms, IV drug use-related osteomyelitis may involve multiple bone sites simultaneously. Vertebral involvement is common (especially cervical and lumbar)
- Unusual organisms: Pseudomonas aeruginosa is characteristically associated with IV drug use osteomyelitis (particularly sternal and vertebral). Candida species should be considered in patients with prior broad-spectrum antibiotic exposure
- Co-occurring endocarditis: Right-sided endocarditis (tricuspid valve) should be evaluated in any IV drug user with osteomyelitis. Order echocardiography (TTE, followed by TEE if TTE is negative and clinical suspicion remains high)
- Adherence challenges: Long IV antibiotic courses through central lines carry diversion risk. OPAT candidacy requires careful assessment; directly observed therapy or oral regimens may be preferred when microbiologically appropriate
NCLEX practice questions
Question 1
A nurse is caring for a patient with sickle cell disease who presents with fever, left tibial pain, and swelling. The provider suspects osteomyelitis. Which organism should the nurse anticipate as the most likely causative agent?
A. Staphylococcus aureus B. Pseudomonas aeruginosa C. Salmonella species D. Staphylococcus epidermidis
Answer: C
Rationale: While S. aureus is the most common cause of osteomyelitis in the general population, Salmonella species are the most common causative organism in patients with sickle cell disease. This is a classic NCLEX association. Patients with sickle cell disease have functional asplenia due to repeated splenic infarctions, which impairs clearance of encapsulated organisms and Salmonella. The infarcted bone in sickle cell disease creates a favorable environment for Salmonella colonization. Pseudomonas is associated with IV drug use. S. epidermidis is associated with orthopedic hardware infections.
Question 2
A patient presents to the emergency department with fever of 39.2°C, right femoral pain, and an elevated CRP of 85 mg/L. The provider orders IV antibiotics for suspected acute osteomyelitis. What is the nurse’s priority action before administering the antibiotics?
A. Obtain a plain radiograph of the right femur B. Obtain two sets of blood cultures from two separate sites C. Apply a cold pack to the right femur to reduce inflammation D. Insert an indwelling urinary catheter to monitor output
Answer: B
Rationale: Blood cultures must be obtained BEFORE administering antibiotics. Once antibiotics are given, the chance of isolating the causative organism from blood decreases significantly. Blood cultures are positive in 30–50% of hematogenous osteomyelitis cases, and a positive result may eliminate the need for an invasive bone biopsy. Two sets from two separate sites are standard to increase sensitivity and help distinguish true bacteremia from contamination. A plain radiograph (A) is appropriate but not the priority — radiographic changes lag 10–14 days behind pathology and will likely be normal in acute presentation. Cold packs (C) and urinary catheter (D) are not the priority action before starting time-sensitive antibiotic therapy.
Question 3
A patient with osteomyelitis is started on empiric antibiotic therapy pending culture results. The wound culture from the initial debridement subsequently grows methicillin-resistant Staphylococcus aureus (MRSA). Which antibiotic should the nurse anticipate as the primary IV agent?
A. Cefazolin B. Nafcillin C. Vancomycin D. Amoxicillin-clavulanate
Answer: C
Rationale: Vancomycin is the drug of choice for MRSA osteomyelitis and is recommended by IDSA guidelines for empiric coverage when MRSA is suspected and as directed therapy when MRSA is confirmed. MRSA is resistant to all beta-lactam antibiotics, which eliminates cefazolin (A), nafcillin (B), and amoxicillin-clavulanate (D). Cefazolin and nafcillin are first-line for methicillin-sensitive S. aureus (MSSA) osteomyelitis. Vancomycin requires monitoring of AUC/MIC (target 400–600) or trough levels, along with renal function monitoring due to nephrotoxicity risk.
Question 4
A nurse is assessing a patient with a 6-month history of osteomyelitis. Which findings should the nurse expect? Select all that apply.
A. Draining sinus tract from the affected bone to the skin B. High-grade fever with rigors C. Low-grade or absent fever D. An area of necrotic bone (sequestrum) visible on imaging E. Elevated ESR F. Rapidly resolving symptoms
Answer: A, C, D, E
Rationale: Chronic osteomyelitis (duration >6 weeks) is characterized by draining sinus tracts (A), which are a hallmark of chronic disease. Fever is typically low-grade or absent (C) between flares — high-grade fever with rigors (B) is more characteristic of acute osteomyelitis or an acute flare. Sequestrum formation (D) — dead, avascular bone that harbors bacteria — is a defining feature of chronic osteomyelitis. ESR remains elevated (E) in chronic infection, though it may be only mildly elevated between flares. Symptoms do not rapidly resolve (F) — chronic osteomyelitis follows a relapsing course and may persist for months to years despite treatment.
Question 5
A home health nurse is visiting a patient receiving outpatient parenteral antibiotic therapy (OPAT) through a PICC line for osteomyelitis. During the visit, the nurse notes erythema and tenderness at the PICC insertion site, and the patient reports a temperature of 38.6°C at home this morning. What is the most appropriate nursing action?
A. Change the PICC dressing and continue monitoring at the next visit B. Flush the PICC line with heparin and reassess in 24 hours C. Hold the antibiotic infusion, obtain peripheral and catheter blood cultures, and notify the provider D. Remove the PICC line and transition to oral antibiotics
Answer: C
Rationale: Erythema and tenderness at the PICC insertion site combined with fever are signs of a possible catheter-related bloodstream infection (CRBSI/CLABSI). The appropriate action is to hold the infusion through the potentially infected line, obtain blood cultures from both a peripheral vein and the catheter (to compare time-to-positivity), and notify the provider for further orders. The provider will determine whether the PICC should be removed or if the patient requires hospital admission. The nurse should not independently remove the PICC line (D) — this is a provider decision that depends on the clinical picture and may require coordination for alternative access. A dressing change alone (A) does not address the systemic signs of infection. Flushing with heparin (B) delays appropriate workup for a potentially serious complication.
Question 6
A nurse educator is teaching nursing students about osteomyelitis diagnostics. A student asks why wound swab cultures are not sufficient for guiding antibiotic therapy. Which response by the nurse educator is most accurate?
A. “Wound swab cultures take too long to process in the microbiology lab.” B. “Surface wound swabs frequently grow colonizing organisms that do not represent the pathogen infecting the bone.” C. “Wound swab cultures cannot identify antibiotic sensitivities.” D. “Wound swab cultures are only accurate for fungal osteomyelitis.”
Answer: B
Rationale: Surface wound swab cultures correlate with bone biopsy cultures in only 30–40% of cases. The skin surface and superficial wound bed are colonized by a variety of organisms (skin flora, environmental organisms) that may not be the same species causing the bone infection. Treatment based on surface swab results may target the wrong organisms, leading to treatment failure. Bone biopsy with culture and histopathology is the gold standard for identifying the causative organism and guiding antibiotic selection. Wound swab cultures do not take excessively long to process (A) — the issue is accuracy. Wound swab cultures can identify antibiotic sensitivities (C) — the problem is that the organism identified may not be the bone pathogen. Wound swabs are not specifically accurate for fungal infections (D).
Related pages
- Fractures nursing reference — fracture classification, compartment syndrome, fat embolism, and the 6 Ps neurovascular assessment used in osteomyelitis monitoring
- Osteoarthritis nursing reference — degenerative joint disease, joint replacement perioperative care, and pain management
- Sepsis nursing reference — Sepsis-3 criteria, the 1-hour SEP-1 bundle, and vasopressor management for hematogenous osteomyelitis complications
- Wound assessment guide — systematic wound evaluation framework for osteomyelitis wound and sinus tract documentation
- Diabetes mellitus nursing reference — diabetic foot management, glycemic control, and peripheral vascular assessment
- AKI nursing reference — nephrotoxicity monitoring during prolonged vancomycin and aminoglycoside therapy
- Nursing lab values cheat sheet — ESR, CRP, WBC, and culture interpretation reference